Online citations, reference lists, and bibliographies.
← Back to Search

Radiogenomic Analysis Of Breast Cancer: Luminal B Molecular Subtype Is Associated With Enhancement Dynamics At MR Imaging.

M. Mazurowski, J. Zhang, L. Grimm, S. Yoon, James I. Silber
Published 2014 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
PURPOSE To investigate associations between breast cancer molecular subtype and semiautomatically extracted magnetic resonance (MR) imaging features. MATERIALS AND METHODS Imaging and genomic data from the Cancer Genome Atlas and the Cancer Imaging Archive for 48 patients with breast cancer from four institutions in the United States were used in this institutional review board approval-exempt study. Computer vision algorithms were applied to extract 23 imaging features from lesions indicated by a breast radiologist on MR images. Morphologic, textural, and dynamic features were extracted. Molecular subtype was determined on the basis of genomic analysis. Associations between the imaging features and molecular subtype were evaluated by using logistic regression and likelihood ratio tests. The analysis controlled for the age of the patients, their menopausal status, and the orientation of the MR images (sagittal vs axial). RESULTS There is an association (P = .0015) between the luminal B subtype and a dynamic contrast material-enhancement feature that quantifies the relationship between lesion enhancement and background parenchymal enhancement. Cancers with a higher ratio of lesion enhancement rate to background parenchymal enhancement rate are more likely to be luminal B subtype. CONCLUSION The luminal B subtype of breast cancer is associated with MR imaging features that relate the enhancement dynamics of the tumor and the background parenchyma.
This paper references
10.1148/radiol.09090838
Cancerous breast lesions on dynamic contrast-enhanced MR images: computerized characterization for image-based prognostic markers.
N. Bhooshan (2010)
10.1007/s10278-012-9506-2
Feature Selection in Computer-Aided Breast Cancer Diagnosis via Dynamic Contrast-Enhanced Magnetic Resonance Images
Megan Rakoczy (2012)
10.1016/j.ctrv.2013.06.006
Breast cancer classification by proteomic technologies: current state of knowledge.
S. W. Lam (2014)
10.1158/0008-5472.CAN-04-4115
Gene expression profiling identifies molecular subtypes of inflammatory breast cancer.
F. Bertucci (2005)
10.1200/JCO.2007.14.4287
Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.
P. Nguyen (2008)
10.1158/1078-0432.CCR-04-2421
Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy
R. Rouzier (2005)
10.1200/JCO.2007.14.5565
Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
M. Kyndi (2008)
10.1158/1078-0432.CCR-06-1109
The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes
L. Carey (2007)
10.1016/j.breast.2012.07.004
Predictive value of breast cancer molecular subtypes in Chinese patients with four or more positive nodes after postmastectomy radiotherapy.
S. Wu (2012)
10.3816/CBC.2007.N.012
Analysis of the pathologic response to primary chemotherapy in patients with locally advanced breast cancer grouped according to estrogen receptor, progesterone receptor, and HER2 status.
L. Fernández-Morales (2007)
10.1200/JCO.2005.02.6914
Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.
V. Guarneri (2006)
10.1158/0008-5472.CAN-07-5644
Subtypes of breast cancer show preferential site of relapse.
M. Smid (2008)
10.1118/1.3691178
Computer-aided diagnosis for dynamic contrast-enhanced breast MRI of mass-like lesions using a multiparametric model combining a selection of morphological, kinetic, and spatiotemporal features.
S. Agliozzo (2012)
10.2214/AJR.11.7824
Radiogenomic analysis of breast cancer using MRI: a preliminary study to define the landscape.
S. Yamamoto (2012)
10.2214/AJR.11.8394
Accuracy and interpretation time of computer-aided detection among novice and experienced breast MRI readers.
C. Lehman (2013)
10.3892/OR_00000752
Molecular subtype can predict the response and outcome of Chinese locally advanced breast cancer patients treated with preoperative therapy.
X. S. Chen (2010)
10.1002/cncr.22981
Molecular classification system identifies invasive breast carcinoma patients who are most likely and those who are least likely to achieve a complete pathologic response after neoadjuvant chemotherapy
N. Goldstein (2007)
10.1007/S12094-008-0265-Y
Tumour molecular subtyping according to hormone receptors and HER2 status defines different pathological complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
A. Sánchez-muñoz (2008)
10.1109/42.668698
A nonparametric method for automatic correction of intensity nonuniformity in MRI data
J. Sled (1998)
10.1007/s10549-011-1709-6
A retrospective study of breast cancer subtypes: the risk of relapse and the relations with treatments
Y. Wang (2011)
10.1016/J.BREAST.2007.02.006
The erbB2+ cluster of the intrinsic gene set predicts tumor response of breast cancer patients receiving neoadjuvant chemotherapy with docetaxel, doxorubicin and cyclophosphamide within the GEPARTRIO trial.
A. Rody (2007)
10.1001/JAMA.295.21.2492
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
L. Carey (2006)
10.1016/j.acra.2010.03.007
Computerized assessment of breast lesion malignancy using DCE-MRI robustness study on two independent clinical datasets from two manufacturers.
W. Chen (2010)
10.1016/j.acra.2011.08.004
A margin sharpness measurement for the diagnosis of breast cancer from magnetic resonance imaging examinations.
Jacob E. D. Levman (2011)
10.1109/TSMC.1973.4309314
Textural Features for Image Classification
R. Haralick (1973)
10.1109/91.413225
On cluster validity for the fuzzy c-means model
N. Pal (1995)
10.1073/pnas.191367098
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T. Sørlie (2001)
10.1245/s10434-009-0606-2
Presenting Features of Breast Cancer Differ by Molecular Subtype
L. Wiechmann (2009)
10.1016/J.CYTOGFR.2005.01.004
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis.
M. Presta (2005)
10.1186/bcr2904
Luminal-B breast cancer and novel therapeutic targets
B. Tran (2011)
10.1118/1.1695652
Computerized interpretation of breast MRI: investigation of enhancement-variance dynamics.
W. Chen (2004)
10.1158/0008-5472.CAN-10-0918
Potential for targeting the fibroblast growth factor receptors in breast cancer.
N. Hynes (2010)
10.1155/2013/872676
Assessment of Feasibility to Use Computer Aided Texture Analysis Based Tool for Parametric Images of Suspicious Lesions in DCE-MR Mammography
M. C. Kale (2013)
10.1016/j.semradonc.2009.05.004
Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy.
K. Huber (2009)
10.1016/J.CCR.2005.09.005
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors.
O. Casanovas (2005)
10.1038/nature11412
Comprehensive molecular portraits of human breast tumors
D. Koboldt (2012)
10.1093/annonc/mds586
Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement.
S. Guiu (2012)
10.1038/35021093
Molecular portraits of human breast tumours
C. Perou (2000)
10.1109/TMI.2012.2219589
A Multichannel Markov Random Field Framework for Tumor Segmentation With an Application to Classification of Gene Expression-Based Breast Cancer Recurrence Risk
A. Ashraf (2013)
10.1016/j.ejrad.2012.03.005
Computed-aided diagnosis (CAD) in the detection of breast cancer.
C. Dromain (2013)
10.1007/s00330-011-2091-9
Computer-aided detection in breast MRI: a systematic review and meta-analysis
M. Dorrius (2011)



This paper is referenced by
10.1371/journal.pone.0171683
Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer
Ming Fan (2017)
10.3390/ijms20236033
TCGA-TCIA Impact on Radiogenomics Cancer Research: A Systematic Review
Mario Zanfardino (2019)
10.1016/j.acra.2018.01.023
Breast Cancer Molecular Subtype Prediction by Mammographic Radiomic Features.
W. Ma (2019)
10.1016/j.acra.2017.05.020
Promoting Collaborations Between Radiologists and Scientists.
John-Paul J. Yu (2018)
10.3892/ol.2018.9312
Intravoxel incoherent motion magnetic resonance imaging for breast cancer: A comparison with benign lesions and evaluation of heterogeneity in different tumor regions with prognostic factors and molecular classification
M. Zhao (2018)
10.1007/s00330-019-06262-0
Optoacoustic imaging of the breast: correlation with histopathology and histopathologic biomarkers
Gisela L. G. Menezes (2019)
10.1016/j.crad.2020.02.011
MRI-based radiogenomics analysis for predicting genetic alterations in oncogenic signalling pathways in invasive breast carcinoma.
Peihong Lin (2020)
10.4048/jbc.2017.20.2.192
Imaging Surveillance for Survivors of Breast Cancer: Correlation between Cancer Characteristics and Method of Detection
A. Chu (2017)
10.3390/cancers11050641
Acute Tumor Transition Angle on Computed Tomography Predicts Chromosomal Instability Status of Primary Gastric Cancer: Radiogenomics Analysis from TCGA and Independent Validation
Ying-Chieh Lai (2019)
10.1016/j.acra.2018.04.019
Additive Benefit of Radiomics Over Size Alone in the Distinction Between Benign Lesions and Luminal A Cancers on a Large Clinical Breast MRI Dataset.
H. M. Whitney (2019)
10.14366/usg.16030
Molecular subtypes and imaging phenotypes of breast cancer
N. Cho (2016)
10.1117/12.2300519
Clinical applications of optical and optoacoustic imaging techniques in the breast
Wei Tse Yang (2018)
10.1109/JPROC.2019.2950187
Comparison of Breast MRI Tumor Classification Using Human-Engineered Radiomics, Transfer Learning From Deep Convolutional Neural Networks, and Fusion Method
H. M. Whitney (2020)
10.1016/j.acra.2019.05.002
Differentiation between Luminal A and B Molecular Subtypes of Breast Cancer Using Pharmacokinetic Quantitative Parameters with Histogram and Texture Features on Preoperative Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Hongbing Luo (2019)
10.1117/12.2217658
Radiogenomic analysis of breast cancer: dynamic contrast enhanced - magnetic resonance imaging based features are associated with molecular subtypes
Shijian Wang (2016)
10.1016/j.acra.2019.09.012
Breast Cancer Radiogenomics: Current Status and Future Directions.
L. Grimm (2020)
10.1002/jmri.26534
Deep learning in radiology: An overview of the concepts and a survey of the state of the art with focus on MRI
M. Mazurowski (2019)
10.1038/s41416-018-0185-8
A machine learning approach to radiogenomics of breast cancer: a study of 922 subjects and 529 DCE-MRI features
Ashirbani Saha (2018)
10.1002/mp.12925
Breast cancer MRI radiomics: An overview of algorithmic features and impact of inter‐reader variability in annotating tumors
Ashirbani Saha (2018)
10.1007/s10278-019-00179-2
Predicting Breast Cancer Molecular Subtype with MRI Dataset Utilizing Convolutional Neural Network Algorithm
R. Ha (2019)
10.1007/s11060-017-2420-1
Radiogenomics of lower-grade glioma: algorithmically-assessed tumor shape is associated with tumor genomic subtypes and patient outcomes in a multi-institutional study with The Cancer Genome Atlas data
M. Mazurowski (2017)
10.5812/IRANJRADIOL.64889
Comparison of Different Dynamic Contrast Enhanced-Magnetic Resonance Imaging Descriptors and Clinical Findings Among Breast Cancer Subtypes Determined Based on Molecular Assessment
S. Doğan (2018)
10.1002/jmri.26762
Background parenchymal enhancement on breast MRI: A comprehensive review
G. Liao (2019)
10.1007/s00261-019-02028-w
Radiogenomics: bridging imaging and genomics
Z. Bodalal (2019)
10.1038/srep17787
Deciphering Genomic Underpinnings of Quantitative MRI-based Radiomic Phenotypes of Invasive Breast Carcinoma
Y. Zhu (2015)
10.1016/j.ejrad.2015.07.012
Recurrence-free survival in breast cancer is associated with MRI tumor enhancement dynamics quantified using computer algorithms.
M. Mazurowski (2015)
10.1002/jmri.24890
Breast cancer subtype intertumor heterogeneity: MRI‐based features predict results of a genomic assay
E. Sutton (2015)
Physically Motivated Feature Development for Machine Learning Applications
Nicholas Czarnek (2017)
10.1148/radiol.2017162823
Heterogeneous Enhancement Patterns of Tumor-adjacent Parenchyma at MR Imaging Are Associated with Dysregulated Signaling Pathways and Poor Survival in Breast Cancer.
J. Wu (2017)
10.1118/1.4955435
Interobserver variability in identification of breast tumors in MRI and its implications for prognostic biomarkers and radiogenomics.
Ashirbani Saha (2016)
10.1007/s00432-018-2595-7
A study of association of Oncotype DX recurrence score with DCE-MRI characteristics using multivariate machine learning models
Ashirbani Saha (2018)
DCE-MRI-based Tumor Subregion Partitioning with Texture Feature Extraction for Prediction of Ki-67 Status of Estrogen Receptor-Positive Breast Cancers
Ming Fan (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar